author-photo

Hank H. Yang

Cedars-Sinai Medical Center

10

Papers

414

Citations

Citation Trend

Filter By

Papers (10) Sort By

Journal Conference Others

Prognostic factors and jaw and renal complications among multiple myeloma patients treated with zoledronic acid.

2011 American Journal of Hematology
Show All
- Source
- Cite
- Save
Citations (16)
A modified regimen of pegylated liposomal doxorubicin, bortezomib and dexamethasone (DVD) is effective and well tolerated for previously untreated multiple myeloma patients

2011 British Journal of Haematology
Show All
- Source
- Cite
- Save
Citations (29)
A phase II study of a modified pegylated liposomal doxorubicin (PLD), bortezomib, and dexamethasone regimen for patients with previously untreated multiple myeloma (MM).

2010 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Factors that determine survival among patients with multiple myeloma (MM) treated with zoledronic acid (ZOL)

2009 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
A088 Overall Survival Among Patients with Multiple Myeloma (MM) Treated with Zoledronic Acid (ZOL)

2009 Clinical Lymphoma, Myeloma & Leukemia
Show All
- Source
- Cite
- Save
Citations (2)
Safety and efficacy of bortezomib and melphalan combination in patients with relapsed or refractory multiple myeloma: updated results of a phase 1/2 study after longer follow-up.

2008 Annals of Hematology
Show All
- Source
- Cite
- Save
Citations (35)
Phase I/II Trial Assessing Bortezomib and Melphalan Combination Therapy for the Treatment of Patients With Relapsed or Refractory Multiple Myeloma

2006 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (199)
Bortezomib in Combination with Melphalan in the Treatment of Relapsed or Refractory Multiple Myeloma: A Phase I/II Study.

2004 Blood
Show All
- Source
- Cite
- Save
Citations (27)
A Prospective, Open-Label Safety and Efficacy Study of Combination Treatment with Bortezomib (PS-341, Velcade™) and Melphalan in Patients with Relapsed or Refractory Multiple Myeloma

2003 Clinical Lymphoma, Myeloma & Leukemia
Show All
- Source
- Cite
- Save
Citations (25)
Overcoming Drug Resistance in Multiple Myeloma: The Emergence of Therapeutic Approaches to Induce Apoptosis

2003 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (81)